Development of a sprayable hydrogel formulation for the skin application of therapeutic antibodies
Publication date
2019-09
Editors
Advisors
Supervisors
Document Type
Article
Metadata
Show full item recordCollections
License
cc_by
Abstract
A formulation of an antibody with antibacterial properties for topical use on Staphylococcal skin infections was developed and characterized. The best formulation was obtained with 1.5% (w/v) sodium carboxymethylcellulose containing 10mg/ml immunoglobulin. Spraying forces and rheological behavior were measured in order to characterize the hydrogel formulation. The percentage of antibody aggregates in gel as well as the antibody release, folding and target binding properties of the released antibody were analyzed to proof an acceptable shelf life and no significant changes in the activity of the antibody over time. No microbial contamination was observed in the chosen non-airless application container. Functional testing of the topical skin formulation was performed with an ex vivo biopsy culture model of dog skin. Histological analysis indicated efficacy in protection from Staphylococcus mediated skin damage and antibody delivery restricted to the epidermal surface. The results demonstrate that this hydrogel is suitable for cutaneous antibody applications in the medical field.
Keywords
drug carrier, anotbody, hydrogel, topical, skin
Citation
Geh, K J, Stelzl, A, Gröne, A, Wagner, L, Förster, B & Winter, G 2019, 'Development of a sprayable hydrogel formulation for the skin application of therapeutic antibodies', European Journal of Pharmaceutics and Biopharmaceutics, vol. 142, pp. 123-132. https://doi.org/10.1016/j.ejpb.2019.06.015